Cargando…
Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence
Osteoarthritis (OA) is the most prevalent joint disease in older people worldwide. Pain owing to OA is considered one of the most frequent causes of chronic pain; however, current pharmacological approaches have some limitations in terms of efficacy and safety. Of note, descending inhibitory pain pa...
Autores principales: | Rinonapoli, Giuseppe, Coaccioli, Stefano, Panella, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529616/ https://www.ncbi.nlm.nih.gov/pubmed/31190964 http://dx.doi.org/10.2147/JPR.S190161 |
Ejemplares similares
-
Where should analgesia lead to? Quality of life and functional recovery with tapentadol
por: Panella, Lorenzo, et al.
Publicado: (2019) -
Pharmacological rationale for tapentadol therapy: a review of new evidence
por: Romualdi, Patrizia, et al.
Publicado: (2019) -
Osteoarthritis: New Insight on Its Pathophysiology
por: Coaccioli, Stefano, et al.
Publicado: (2022) -
Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings
por: Alshehri, Fahad S
Publicado: (2023) -
A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A Review
por: Varrassi, Giustino, et al.
Publicado: (2018)